| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698027 | Clinical Oncology | 2017 | 8 Pages |
Abstract
Our findings suggest that patients with less FDG-avid tumours are less likely to metastasise and may therefore benefit from upfront local treatment intensification.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J.M. Wilson, S. Mukherjee, T.B. Brunner, M. Partridge, M.A. Hawkins,